<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To investigate the effect of <z:chebi fb="0" ids="38561,38562">fluvastatin</z:chebi> on <z:chebi fb="0" ids="11230">lysophosphatidylcholine</z:chebi> (LPC)-induced <z:hpo ids='HP_0004308'>ventricular arrhythmias</z:hpo> and its mechanism </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Twenty male SD rats were randomly allocated into two equal groups, namely LPC treatment group and <z:chebi fb="0" ids="38561,38562">fluvastatin</z:chebi> pretreatment group </plain></SENT>
<SENT sid="2" pm="."><plain>Langendorff apparatus was used for cardiac perfusion ex vivo with 5 µmol/L LPC for 5 min followed by washing for 30 min in LPC treatment group, and in <z:chebi fb="0" ids="38561,38562">fluvastatin</z:chebi> pretreatment group, a 30-min perfusion with 10 µmol/L <z:chebi fb="0" ids="38561,38562">fluvastatin</z:chebi> was administered before LPC perfusion </plain></SENT>
<SENT sid="3" pm="."><plain>The LPC-induced nonselective <z:chebi fb="36" ids="36916">cation</z:chebi> current (I(NSC)) in the ventricular myocytes was recorded using the whole-cell voltage-clamp method </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: <z:chebi fb="0" ids="38561,38562">Fluvastatin</z:chebi> significantly inhibited LPC-induced ventricular tachyarrhythmia/<z:mp ids='MP_0006109'>fibrillation</z:mp> and I(NSC) </plain></SENT>
<SENT sid="5" pm="."><plain>The small G-protein Rho inhibitor (C3) and Rho-kinase inhibitor (Y-27632) in the pipette solution also suppressed LPC-induced I(NSC) </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSION: <z:chebi fb="0" ids="38561,38562">Fluvastatin</z:chebi> offers cardiac protection against LPC by inhibiting LPC-induced I(NSC) </plain></SENT>
<SENT sid="7" pm="."><plain>LPC induces fatal <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> via a Rho/Rho-kinase-mediated pathway </plain></SENT>
</text></document>